Why š¦ CompanyFundraising picked: Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
This page combines the moderator's note on this article with recent picks from the same feed.
Source: techcrunch.com
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Lead moderator note on this article
This is an announcement regarding Enveda's recent $311 million funding round.
Additional moderation notes
š¦ CompanyFundraising
This is an announcement regarding Enveda's recent $311 million funding round.
What this feed curates
News on Startup Funding Rounds and IPOs
Recent picks from this moderator
Ema raises $77M as AI starts eating into enterprise software and services
This article reports on Ema successfully raising $77 million in a new funding round.
Snorkel AI triples valuation to $3.5B as demand for AI training data booms
This is a detailed look at Snorkel AI's massive funding round and soaring valuation amid the ongoing artificial intelligence boom.
Singaporeās Nexstrom wants to bring 2D semiconductors to chip fabs
Here is the latest news on Nexstrom securing new funding to scale up their 2D semiconductor manufacturing equipment.